LAST UPDATED: OCTOBER 1, 2026
This blog is a place to better understand biotech, not a substitute for your own research or professional advice.
1. Educational commentary, not professional advice
INTO BIOTECH provides educational information and personal commentary about biotechnology, drug development, clinical research, and biotech stocks. Nothing on this site is individualized investment, financial, legal, tax, medical, or regulatory advice. References to a company, security, product, technology, or clinical program are not recommendations or offers to buy, sell, or hold any security.
2. Personal views, not an employer’s position
The author is currently employed in the biopharma industry and does not disclose their name or employer to protect professional privacy. All views are expressed in a personal capacity. They do not represent, and should not be attributed to, any current or former employer, affiliate, client, or other organization. Professional experience does not imply employer endorsement of this blog.
3. Public information and professional confidentiality
This blog is intended to discuss publicly available information through the lens of industry experience. It is not a source of confidential employer information, proprietary information, or material nonpublic information. An industry background should not be interpreted as access to undisclosed company developments or privileged investment information.
4. Qualifications and their limits
The author has 15 years of biopharma R&D experience, holds a pharmacist license in South Korea, and has experience with pharmaceutical development and regulatory affairs, with particular expertise in targeted drug delivery. References to 35+ patents concern patent applications, not a representation that 35+ patents have been granted. A South Korean pharmacist license does not imply a license to practice pharmacy in the United States. Reading this blog does not establish a pharmacist-patient, advisory, or other professional relationship.
5. Investment and development risks
Biotech investing can involve substantial volatility and loss, including the loss of the entire amount invested. Clinical failure, safety findings, regulatory setbacks, financing needs, dilution, competition, and commercialization challenges can materially affect a company. Scientific promise does not guarantee clinical success, regulatory approval, commercial viability, or investment returns. Forward-looking views are uncertain and may not occur.
6. Evidence, interpretation, and accuracy
Scientific findings, clinical results, regulatory interpretations, and market conditions can change. Commentary may include interpretations, estimates, and opinions, which should be distinguished from established facts. While reasonable care is taken, no guarantee is made that information is accurate, complete, current, or suitable for your circumstances. Check original publications, trial records, company filings, and official regulatory sources before relying on a claim. Content may be revised or corrected.
7. Potential financial interests
The author may hold positions in securities discussed, and views or positions may change. Financial interests can create conflicts of interest; readers should not assume that the author has no interest in a company mentioned. Consider any article-specific disclosures alongside the commentary, and conduct your own due diligence.
8. Your decisions and appropriate professional guidance
You remain responsible for your own investment and other decisions. Consider your financial circumstances, objectives, and risk tolerance, and consult appropriately qualified professionals when needed. Do not use this blog to diagnose, treat, or manage a medical condition, or to replace advice from a licensed healthcare professional.